Associate Professor Natalie Staplin
Natalie Staplin
PhD
Senior Statistician
Natalie is a Senior Statistician within the Renal Studies Group at the Clinical Trials Service Unit & Epidemiological Studies Unit (CTSU). She is also a lecturer on the MSc in Global Health Sciences.
Natalie joined CTSU in 2012 after completing an undergraduate degree in Mathematics with Actuarial Science and a PhD in Statistics.
Her current research interests are epidemiological analyses of patients with chronic kidney disease to identify risk factors associated with vascular events or progression to end-stage renal disease.
She is particularly interested in competing risks methodology and the use of directed acyclic graphs in observational analyses.
Recent publications
-
A Mendelian randomisation study of the effect of body mass index on 52 causes of death among 125 000 Mexican adults with admixed ancestry
Journal article
Gnatiuc Friedrichs L. et al, (2025), International Journal of Epidemiology
-
An application of the MR-Horse method to reduce selection bias in genome-wide association studies of disease progression.
Journal article
Donovan K. et al, (2025), Eur J Hum Genet
-
Molnupiravir or nirmatrelvir-ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19: a randomised, controlled, open-label, platform trial (RECOVERY)
Journal article
HORBY PW. et al, (2025), The Lancet Infectious Diseases
-
MORTALITY RISKS IN SUBTYPES OF WHITE-COAT HYPERTENSION: IMPLICATIONS FOR THE DIAGNOSIS OF WHITE-COAT HYPERTENSION
Journal article
De la Sierra A. et al, (2025), Journal of Hypertension, 43, e11 - e12
-
Empagliflozin lowers serum uric acid in chronic kidney disease: exploratory analyses from the EMPA-KIDNEY trial.
Journal article
Mayne KJ. et al, (2025), Nephrol Dial Transplant, 40, 720 - 730